FDAsafety guidance66% confidence
Meta Labs Pharmaceuticals, LLC - 725130 - 05/15/2026
Source: FDA
Why This Matters
Why this matters: sets a safety guidance precedent in the same sub-indication (ophthalmology) as THEA PHARMA; the same agency is already in play for this signal, so precedent weight is higher.
Regulatory Analysis
Supporting Context
- Therapeutic area
- Ophthalmology · Glaucoma
- Sub-indication
- Ophthalmology
Related signal: FDA Accepts Application for COSOPT PF Supplement by THEA PHARMA